AI-Assisted Drug Repurposing What if the next breakthrough treatment is already available today? It could be hidden within an existing drug, waiting to be discovered. This idea drives the growing field of AI-assisted drug repurposing. The approach looks for new therapeutic uses for approved medications. Traditional drug development can cost billions and take more than…
The promise of Artificial Intelligence (AI) in life sciences is undeniable—offering advancements in drug discovery, clinical research, and evidence generation. Yet, many organizations still struggle to implement AI effectively. To better understand these challenges, CapeStart conducted a survey of 104 life science professionals, asking them: What are the top three barriers to success for your…
Across industries, businesses are turning to AI to address pressing challenges, drive innovation, and improve efficiency. According to CapeStart’s Life Science AI Research Report, organizations are increasingly identifying specific areas where AI can deliver the greatest value. By focusing on key business functions, companies aim to unlock new opportunities, streamline operations, and enhance their impact…
